22nd Century Group Inc (XXII)

[Justfactsmam]

Some investors question whether XXII, as a biotech stock, is a bit more risky?

IMHO...XXII is NOT a true biotech stock. Its a hybrid.

It will have a basic "staples" business with or without FDA, and it can flourish elsewhere (outside the U.S.) and quite handsomely.

The biotech aspect is the FDA designation as VLN...which is just a bonus, not a necessity for XXII to be an overwhelming success OUTSIDE the U.S ...where the growing market is.